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POLICY STATEMENT
Year 2007 Position Statement:
Principles and Guidelines for Early
Hearing Detection and Intervention
Programs
Joint Committee on Infant Hearing
THE POSITION STATEMENT
The Joint Committee on Infant Hearing (JCIH) endorses early detection of and
intervention for infants with hearing loss. The goal of early hearing detection and
intervention (EHDI) is to maximize linguistic competence and literacy develop-
ment for children who are deaf or hard of hearing. Without appropriate oppor-
tunities to learn language, these children will fall behind their hearing peers in
communication, cognition, reading, and social-emotional development. Such de-
lays may result in lower educational and employment levels in adulthood.1 To
maximize the outcome for infants who are deaf or hard of hearing, the hearing of
all infants should be screened at no later than 1 month of age. Those who do not
pass screening should have a comprehensive audiological evaluation at no later
than 3 months of age. Infants with confirmed hearing loss should receive appro-
priate intervention at no later than 6 months of age from health care and educa-
tion professionals with expertise in hearing loss and deafness in infants and young
children. Regardless of previous hearing-screening outcomes, all infants with or
without risk factors should receive ongoing surveillance of communicative devel-
opment beginning at 2 months of age during well-child visits in the medical
home.2 EHDI systems should guarantee seamless transitions for infants and their
families through this process.
2007 JCIH POSITION STATEMENT UPDATES
The following are highlights of updates made since the 2000 JCIH statement3:
1. Definition of targeted hearing loss
● The definition has been expanded from congenital permanent bilateral, uni-
lateral sensory, or permanent conductive hearing loss to include neural
hearing loss (eg, “auditory neuropathy/dyssynchrony”) in infants admitted to
the NICU.
2. Hearing-screening and -rescreening protocols
● Separate protocols are recommended for NICU and well-infant nurseries.
NICU infants admitted for more than 5 days are to have auditory brainstem
response (ABR) included as part of their screening so that neural hearing loss
will not be missed.
● For infants who do not pass automated ABR testing in the NICU, referral
should be made directly to an audiologist for rescreening and, when indi-
cated, comprehensive evaluation including ABR.
● For rescreening, a complete screening on both ears is recommended, even if
only 1 ear failed the initial screening.
● For readmissions in the first month of life for all infants (NICU or well infant),
when there are conditions associated with potential hearing loss (eg, hyper-
www.pediatrics.org/cgi/doi/10.1542/
peds.2007-2333
doi:10.1542/peds.2007-2333
All policy statements from the American
Academy of Pediatrics automatically
expire 5 years after publication unless
reafﬁrmed, revised, or retired at or
before that time.
KeyWord
hearing screening
Abbreviations
JCIH—Joint Committee on Infant Hearing
EHDI—early hearing detection and
intervention
ABR—auditory brainstem response
CMV—cytomegalovirus
ECMO—extracorporeal membrane
oxygenation
AAP—American Academy of Pediatrics
MCHB—Maternal and Child Health Bureau
HRSA—Health Resources and Services
Administration
NIDCD—National Institute on Deafness
and Other Communication Disorders
CDC—Centers for Disease Control and
Prevention
UNHS—universal newborn hearing
screening
OAE—otoacoustic emission
IFSP—individualized family service plan
OME—otitis media with effusion
FM—frequency modulation
DSHPSHWA—Directors of Speech and
Hearing Programs in State Health and
Welfare Agencies
GPRA—Government Performance and
Results Act
OMB—Ofﬁce of Management and
Budgets
PEDIATRICS (ISSN Numbers: Print, 0031-4005;
Online, 1098-4275). Copyright © 2007 by the
American Academy of Pediatrics
898 AMERICAN ACADEMY OF PEDIATRICS
 by guest on April 25, 2012pediatrics.aappublications.orgDownloaded from 
bilirubinemia that requires exchange transfusion or
culture-positive sepsis), a repeat hearing screening
is recommended before discharge.
3. Diagnostic audiology evaluation
● Audiologists with skills and expertise in evaluating
newborn and young infants with hearing loss
should provide audiology diagnostic and auditory
habilitation services (selection and fitting of ampli-
fication device).
● At least 1 ABR test is recommended as part of a
complete audiology diagnostic evaluation for chil-
dren younger than 3 years for confirmation of per-
manent hearing loss.
● The timing and number of hearing reevaluations
for children with risk factors should be customized
and individualized depending on the relative like-
lihood of a subsequent delayed-onset hearing loss.
Infants who pass the neonatal screening but have a
risk factor should have at least 1 diagnostic audiol-
ogy assessment by 24 to 30 months of age. Early
and more frequent assessment may be indicated for
children with cytomegalovirus (CMV) infection,
syndromes associated with progressive hearing loss,
neurodegenerative disorders, trauma, or culture-
positive postnatal infections associated with senso-
rineural hearing loss; for children who have re-
ceived extracorporeal membrane oxygenation
(ECMO) or chemotherapy; and when there is care-
giver concern or a family history of hearing loss.
● For families who elect amplification, infants in
whom permanent hearing loss is diagnosed should
be fitted with an amplification device within 1
month of diagnosis.
4. Medical evaluation
● For infants with confirmed hearing loss, a genetics
consultation should be offered to their families.
● Every infant with confirmed hearing loss should be
evaluated by an otolaryngologist who has knowl-
edge of pediatric hearing loss and have at least 1
examination to assess visual acuity by an ophthal-
mologist who is experienced in evaluating infants.
● The risk factors for congenital and acquired hearing
loss have been combined in a single list rather than
grouped by time of onset.
5. Early intervention
● All families of infants with any degree of bilateral or
unilateral permanent hearing loss should be con-
sidered eligible for early intervention services.
● There should be recognized central referral points
of entry that ensure specialty services for infants
with confirmed hearing loss.
● Early intervention services for infants with con-
firmed hearing loss should be provided by profes-
sionals who have expertise in hearing loss, includ-
ing educators of the deaf, speech-language
pathologists, and audiologists.
● In response to a previous emphasis on “natural
environments,” the JCIH recommends that both
home-based and center-based intervention options
be offered.
6. Surveillance and screening in the medical home
● For all infants, regular surveillance of developmen-
tal milestones, auditory skills, parental concerns,
and middle-ear status should be performed in the
medical home, consistent with the American Acad-
emy of Pediatrics (AAP) pediatric periodicity sched-
ule. All infants should have an objective standard-
ized screening of global development with a
validated assessment tool at 9, 18, and 24 to 30
months of age or at any time if the health care
professional or family has concern.
● Infants who do not pass the speech-language por-
tion of a medical home global screening or for
whom there is a concern regarding hearing or lan-
guage should be referred for speech-language eval-
uation and audiology assessment.
7. Communication
● The birth hospital, in collaboration with the state
EHDI coordinator, should ensure that the hearing-
screening results are conveyed to the parents and
the medical home.
● Parents should be provided with appropriate fol-
low-up and resource information, and hospitals
should ensure that each infant is linked to a med-
ical home.
● Information at all stages of the EHDI process is to be
communicated to the family in a culturally sensi-
tive and understandable format.
● Individual hearing-screening information and au-
diology diagnostic and habilitation information
should be promptly transmitted to the medical
home and the state EHDI coordinator.
● Families should be made aware of all communica-
tion options and available hearing technologies
(presented in an unbiased manner). Informed fam-
ily choice and desired outcome guide the decision-
making process.
8. Information infrastructure
● States should implement data-management and
-tracking systems as part of an integrated child
health information system to monitor the quality of
EHDI services and provide recommendations for
improving systems of care.
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● An effective link between health and education
professionals is needed to ensure successful transi-
tion and to determine outcomes of children with
hearing loss for planning and establishing public
health policy.
BACKGROUND
It has long been recognized that unidentified hearing
loss at birth can adversely affect speech and language
development as well as academic achievement and so-
cial-emotional development. Historically, moderate-to-
severe hearing loss in young children was not detected
until well beyond the newborn period, and it was not
unusual for diagnosis of milder hearing loss and unilat-
eral hearing loss to be delayed until children reached
school age.
In the late 1980s, Dr C. Everett Koop, then US Sur-
geon General, on learning of new technology, encour-
aged detection of hearing loss to be included in the
Healthy People 20004 goals for the nation. In 1988, the
Maternal and Child Health Bureau (MCHB), a division
of the US Health Resources and Services Administration
(HRSA), funded pilot projects in Rhode Island, Utah, and
Hawaii to test the feasibility of a universal statewide
screening program to screen newborn infants for hear-
ing loss before hospital discharge. The National Institutes
of Health, through the National Institute on Deafness
and Other Communication Disorders (NIDCD), issued in
1993 a consensus statement on early identification of
hearing impairment in infants and young children.5 In
the statement the authors concluded that all infants
admitted to the NICU should be screened for hearing loss
before hospital discharge and that universal screening
should be implemented for all infants within the first 3
months of life.4 In its 1994 position statement, the JCIH
endorsed the goal of universal detection of infants with
hearing loss and encouraged continuing research and
development to improve methods for identification of
and intervention for hearing loss.6,7 The AAP released a
statement that recommended newborn hearing screen-
ing and intervention in 1999.8 In 2000, citing advances
in screening technology, the JCIH endorsed the univer-
sal screening of all infants through an integrated, inter-
disciplinary system of EHDI.3 The Healthy People 2010
goals included an objective to “increase the proportion of
newborns who are screened for hearing loss by one
month, have audiological evaluation by 3 months, and
are enrolled in appropriate intervention services by 6
months.”9
The ensuing years have seen remarkable expansion in
newborn hearing screening. At the time of the National
Institutes of Health consensus statement, only 11 hospi-
tals in the United States were screening more than 90%
of their newborn infants. In 2000, through the support
of Representative Jim Walsh (R-NY), Congress autho-
rized the HRSA to develop newborn hearing screening
and follow-up services, the Centers for Disease Control
and Prevention (CDC) to develop data and tracking sys-
tems, and the NIDCD to support research in EHDI. By
2005, every state had implemented a newborn hearing-
screening program, and approximately 95% of newborn
infants in the United States were screened for hearing
loss before hospital discharge. Congress recommended
cooperation and collaboration among several federal
agencies and advocacy organizations to facilitate and
support the development of state EHDI systems.
EHDI programs throughout the United States have
demonstrated not only the feasibility of universal new-
born hearing screening (UNHS) but also the benefits of
early identification and intervention. There is a growing
body of literature indicating that when identification
and intervention occur at no later than 6 months of age
for newborn infants who are deaf or hard of hearing, the
infants perform as much as 20 to 40 percentile points
higher on school-related measures (vocabulary, articu-
lation, intelligibility, social adjustment, and behav-
ior).10–13 Still, many important challenges remain. De-
spite the fact that approximately 95% of newborn
infants have their hearing screened in the United States,
almost half of newborn infants who do not pass the
initial screening do not have appropriate follow-up to
either confirm the presence of a hearing loss and/or
initiate appropriate early intervention services (see
www.infanthearing.org, www.cdc.gov/ncbddd/ehdi, and
www.nidcd.nih.gov/health).
State EHDI coordinators report system-wide problems
including failure to communicate information to families
in a culturally sensitive and understandable format at all
stages of the EHDI process, lack of integrated state data-
management and -tracking systems, and a shortage of
facilities and personnel with the experience and exper-
tise needed to provide follow-up for infants who are
referred from newborn screening programs.14 Available
data indicate that a significant number of children who
need further assessment do not receive appropriate fol-
low-up evaluations. However, the outlook is improving
as EHDI programs focus on the importance of strength-
ening follow-up and intervention.
PRINCIPLES
All children with hearing loss should have access to
resources necessary to reach their maximum potential.
The following principles provide the foundation for ef-
fective EHDI systems and have been updated and ex-
panded since the 2000 JCIH position statement.
1. All infants should have access to hearing screening
using a physiologic measure at no later than 1 month
of age.
2. All infants who do not pass the initial hearing screen-
ing and the subsequent rescreening should have ap-
propriate audiological and medical evaluations to
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confirm the presence of hearing loss at no later than
3 months of age.
3. All infants with confirmed permanent hearing loss
should receive early intervention services as soon as
possible after diagnosis but at no later than 6 months
of age. A simplified, single point of entry into an
intervention system that is appropriate for children
with hearing loss is optimal.
4. The EHDI system should be family centered with
infant and family rights and privacy guaranteed
through informed choice, shared decision-making,
and parental consent in accordance with state and
federal guidelines. Families should have access to in-
formation about all intervention and treatment op-
tions and counseling regarding hearing loss.
5. The child and family should have immediate access to
high-quality technology including hearing aids, co-
chlear implants, and other assistive devices when ap-
propriate.
6. All infants and children should be monitored for
hearing loss in the medical home.15 Continued assess-
ment of communication development should be pro-
vided by appropriate professionals to all children with
or without risk indicators for hearing loss.
7. Appropriate interdisciplinary intervention programs
for infants with hearing loss and their families should
be provided by professionals who are knowledgeable
about childhood hearing loss. Intervention programs
should recognize and build on strengths, informed
choices, traditions, and cultural beliefs of the families.
8. Information systems should be designed and imple-
mented to interface with electronic health charts and
should be used to measure outcomes and report the
effectiveness of EHDI services at the patient, practice,
community, state, and federal levels.
GUIDELINES FOR EHDI PROGRAMS
The 2007 guidelines were developed to update the 2000
JCIH position statement principles and to support the
goals of universal access to hearing screening, evalua-
tion, and intervention for newborn and young infants
embodied in Healthy People 2010.9 The guidelines provide
current information on the development and implemen-
tation of successful EHDI systems.
Hearing screening should identify infants with specif-
ically defined hearing loss on the basis of investigations
of long-term, developmental consequences of hearing
loss in infants, currently available physiologic screening
techniques, and availability of effective intervention in
concert with established principles of health screen-
ing.15–18 Studies have demonstrated that current screen-
ing technologies are effective in identifying hearing loss
of moderate and greater degree.19 In addition, studies of
children with permanent hearing loss indicate that mod-
erate or greater degrees of hearing loss can have signif-
icant effects on language, speech, academic, and social-
emotional development.20 High-risk target populations
also include infants in the NICU, because research data
have indicated that this population is at highest risk of
having neural hearing loss.21–23
The JCIH, however, is committed to the goal of iden-
tifying all degrees and types of hearing loss in childhood
and recognizes the developmental consequences of even
mild degrees of permanent hearing loss. Recent evi-
dence, however, has suggested that current hearing-
screening technologies fail to identify some infants with
mild forms of hearing loss.24,25 In addition, depending on
the screening technology selected, infants with hearing
loss related to neural conduction disorders or “auditory
neuropathy/auditory dyssynchrony” may not be de-
tected through a UNHS program. Although the JCIH
recognizes that these disorders may result in delayed
communication,26–28 currently recommended screening
algorithms (ie, use of otoacoustic emission [OAE] testing
alone) preclude universal screening for these disorders.
Because these disorders typically occur in children who
require NICU care,21 the JCIH recommends screening
this group with the technology capable of detecting au-
ditory neuropathy/dyssynchrony: automated ABR mea-
surement.
All infants, regardless of newborn hearing-screening
outcome, should receive ongoing monitoring for devel-
opment of age-appropriate auditory behaviors and com-
munication skills. Any infant who demonstrates delayed
auditory and/or communication skills development,
even if he or she passed newborn hearing screening,
should receive an audiological evaluation to rule out
hearing loss.
Roles and Responsibilities
The success of EHDI programs depends on families
working in partnership with professionals as a well-
coordinated team. The roles and responsibilities of each
team member should be well defined and clearly under-
stood. Essential team members are the birth hospital,
families, pediatricians or primary health care profession-
als (ie, the medical home), audiologists, otolaryngolo-
gists, speech-language pathologists, educators of chil-
dren who are deaf or hard of hearing, and other early
intervention professionals involved in delivering EHDI
services.29,30 Additional services including genetics, oph-
thalmology, developmental pediatrics, service coordina-
tion, supportive family education, and counseling
should be available.31
The birth hospital is a key member of the team. The
birth hospital, in collaboration with the state EHDI co-
ordinator, should ensure that parents and primary
health care professionals receive and understand the
hearing-screening results, that parents are provided with
appropriate follow-up and resource information, and
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that each infant is linked to a medical home.2 The hos-
pital ensures that hearing-screening information is
transmitted promptly to the medical home and appro-
priate data are submitted to the state EHDI coordinator.
The most important role for the family of an infant
who is deaf or hard of hearing is to love, nurture, and
communicate with the infant. From this foundation,
families usually develop an urgent desire to understand
and meet the special needs of their infant. Families gain
knowledge, insight, and experience by accessing re-
sources and through participation in scheduled early
intervention appointments including audiological, med-
ical, habilitative, and educational sessions. This experi-
ence can be enhanced when families choose to become
involved with parental support groups, people who are
deaf or hard of hearing, and/or their children’s deaf or
hard-of-hearing peers. Informed family choices and de-
sired outcomes guide all decisions for these children. A
vital function of the family’s role is ensuring direct access
to communication in the home and the daily provision
of language-learning opportunities. Over time, the child
benefits from the family’s modeling of partnerships with
professionals and advocating for their rights in all set-
tings. The transfer of responsibilities from families to the
child develops gradually and increases as the child ma-
tures, growing in independence and self-advocacy.
Pediatricians, family physicians, and other allied
health care professionals, working in partnership with
parents and other professionals such as audiologists,
therapists, and educators, constitute the infant’s medical
home.2 A medical home is defined as an approach to
providing health care services with which care is acces-
sible, family centered, continuous, comprehensive, co-
ordinated, compassionate, and culturally competent.
The primary health care professional acts in partnership
with parents in a medical home to identify and access
appropriate audiology, intervention, and consultative
services that are needed to develop a global plan of
appropriate and necessary health and habilitative care
for infants identified with hearing loss and infants with
risk factors for hearing loss. All children undergo sur-
veillance for auditory skills and language milestones.
The infant’s pediatrician, family physician, or other pri-
mary health care professional is in a position to advocate
for the child and family.2,16
An audiologist is a person who, by virtue of academic
degree, clinical training, and license to practice, is qual-
ified to provide services related to the prevention of
hearing loss and the audiological diagnosis, identifica-
tion, assessment, and nonmedical and nonsurgical treat-
ment of persons with impairment of auditory and ves-
tibular function, and to the prevention of impairments
associated with them. Audiologists serve in a number of
roles. They provide newborn hearing-screening program
development, management, quality assessment, service
coordination and referral for audiological diagnosis, and
audiological treatment and management. For the fol-
low-up component, audiologists provide comprehensive
audiological diagnostic assessment to confirm the exis-
tence of the hearing loss, ensure that parents understand
the significance of the hearing loss, evaluate the infant
for candidacy for amplification and other sensory devices
and assistive technology, and ensure prompt referral to
early intervention programs. For the treatment and
management component, audiologists provide timely
fitting and monitoring of amplification devices.32 Other
audiologists may provide diagnostic and auditory treat-
ment and management services in the educational set-
ting and provide a bridge between the child/family and
the audiologist in the clinic setting as well as other
service providers. Audiologists also provide services as
teachers, consultants, researchers, and administrators.
Otolaryngologists are physicians whose specialty in-
cludes determining the etiology of hearing loss; identi-
fying related risk indicators for hearing loss, including
syndromes that involve the head and neck; and evalu-
ating and treating ear diseases. An otolaryngologist with
knowledge of childhood hearing loss can determine if
medical and/or surgical intervention may be appropri-
ate. When medical and/or surgical intervention is pro-
vided, the otolaryngologist is involved in the long-term
monitoring and follow-up with the infant’s medical
home. The otolaryngologist provides information and
participates in the assessment of candidacy for amplifi-
cation, assistive devices, and surgical intervention, in-
cluding reconstruction, bone-anchored hearing aids, and
cochlear implantation.
Early intervention professionals are trained in a vari-
ety of academic disciplines such as speech-language pa-
thology, audiology, education of children who are deaf
or hard of hearing, service coordination, or early child-
hood special education. All individuals who provide ser-
vices to infants with hearing loss should have specialized
training and expertise in the development of audition,
speech, and language. Speech-language pathologists
provide both evaluation and intervention services for
language, speech, and cognitive-communication devel-
opment. Educators of children who are deaf or hard of
hearing integrate the development of communicative
competence within a variety of social, linguistic, and
cognitive/academic contexts. Audiologists may provide
diagnostic and habilitative services within the individu-
alized family service plan (IFSP) or school-based individ-
ualized education plan. To provide the highest quality of
intervention, more than 1 provider may be required.
The care coordinator is an integral member of the
EHDI team and facilitates the family’s transition from
screening to evaluation to early intervention.33 This per-
son must be a professional (eg, social worker, teacher,
nurse) who is knowledgeable about hearing loss. The
care coordinator incorporates the family’s preferences
for outcomes into an IFSP as required by federal legisla-
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tion. The care coordinator supports the family members
in their choice of the infant’s communicative develop-
ment. Through the IFSP review, the infant’s progress in
language, motor, cognitive, and social-emotional devel-
opment is monitored. The care coordinator assists the
family in advocating for the infant’s unique develop-
mental needs.
The deaf and hard-of-hearing community includes
members with direct experience with signed language,
spoken language, hearing-aid and cochlear implant use,
and other communication strategies and technologies.
Optimally, adults who are deaf or hard-of-hearing
should play an integral part in the EHDI program. Both
adults and children in the deaf and hard-of-hearing
community can enrich the family’s experience by serv-
ing as mentors and role models. Such mentors have
experience in negotiating their way in a hearing world,
raising infants or children who are deaf or hard of hear-
ing, and providing families with a full range of informa-
tion about communication options, assistive technology,
and resources that are available in the community.
A successful EHDI program requires collaboration be-
tween a variety of public and private institutions and
agencies that assume responsibility for specific compo-
nents (eg, screening, evaluation, intervention). Roles
and responsibilities may differ from state to state. Each
state has defined a lead coordinating agency with over-
sight responsibility. The lead coordinating agency in
each state should be responsible for identifying the pub-
lic and private funding sources available to develop,
implement, and coordinate EHDI systems.
Hearing Screening
Multidisciplinary teams of professionals, including audi-
ologists, physicians, and nursing personnel, are needed
to establish the UNHS component of EHDI programs. All
team members work together to ensure that screening
programs are of high quality and are successful. An
audiologist should be involved in each component of the
hearing-screening program, particularly at the level of
statewide implementation and, whenever possible, at
the individual hospital level. Hospitals and agencies
should also designate a physician to oversee the medical
aspects of the EHDI program.
Each team of professionals responsible for the hospi-
tal-based UNHS program should review the hospital in-
frastructure in relationship to the screening program.
Hospital-based programs should consider screening
technology (ie, OAE or automated ABR testing); validity
of the specific screening device; screening protocols, in-
cluding the timing of screening relative to nursery dis-
charge; availability of qualified screening personnel;
suitability of the acoustical and electrical environments;
follow-up referral criteria; referral pathways for follow-
up; information management; and quality control and
improvement. Reporting and communication protocols
must be well defined and include the content of reports
to physicians and parents, documentation of results in
medical charts, and methods for reporting to state reg-
istries and national data sets.
Physiologic measures must be used to screen new-
borns and infants for hearing loss. Such measures in-
clude OAE and automated ABR testing. Both OAE and
automated ABR technologies provide noninvasive re-
cordings of physiologic activity underlying normal audi-
tory function, both are easily performed in neonates and
infants, and both have been successfully used for
UNHS.19,34–37 However, there are important differences
between the 2 measures. OAE measurements are ob-
tained from the ear canal by using a sensitive micro-
phone within a probe assembly that records cochlear
responses to acoustic stimuli. Thus, OAEs reflect the
status of the peripheral auditory system extending to the
cochlear outer hair cells. In contrast, ABRmeasurements
are obtained from surface electrodes that record neural
activity generated in the cochlea, auditory nerve, and
brainstem in response to acoustic stimuli delivered via
an earphone. Automated ABR measurements reflect the
status of the peripheral auditory system, the eighth
nerve, and the brainstem auditory pathway.
Both OAE and ABR screening technologies can be
used to detect sensory (cochlear) hearing loss19; how-
ever, both technologies may be affected by outer or
middle-ear dysfunction. Consequently, transient condi-
tions of the outer and middle ear may result in a “failed”
screening-test result in the presence of normal cochlear
and/or neural function.38 Moreover, because OAEs are
generated within the cochlea, OAE technology cannot
be used to detect neural (eighth nerve or auditory brain-
stem pathway) dysfunction. Thus, neural conduction
disorders or auditory neuropathy/dyssynchrony without
concomitant sensory dysfunction will not be detected by
OAE testing.
Some infants who pass newborn hearing screening
will later demonstrate permanent hearing loss.25 Al-
though this loss may reflect delayed-onset hearing loss,
both ABR and OAE screening technologies will miss
some hearing loss (eg, mild or isolated frequency region
losses).
Interpretive criteria for pass/fail outcomes should re-
flect clear scientific rationale and should be evidence
based.39,40 Screening technologies that incorporate auto-
mated-response detection are necessary to eliminate the
need for individual test interpretation, to reduce the
effects of screener bias or operator error on test outcome,
and to ensure test consistency across infants, test condi-
tions, and screening personnel.41–45 When statistical
probability is used to make pass/fail decisions, as is the
case for OAE and automated ABR screening devices, the
likelihood of obtaining a pass outcome by chance alone
is increased when screening is performed repeatedly.46–48
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This principle must be incorporated into the policies of
rescreening.
There are no national standards for the calibration of
OAE or ABR instrumentation. Compounding this prob-
lem, there is a lack of uniform performance standards.
Manufacturers of hearing-screening devices do not al-
ways provide sufficient supporting evidence to validate
the specific pass/fail criteria and/or automated algo-
rithms used in their instruments.49 In the absence of
national standards, audiologists must obtain normative
data for the instruments and protocols they use.
The JCIH recognizes that there are important issues
differentiating screening performed in the well-infant
nursery from that performed in the NICU. Although the
goals in each nursery are the same, numerous method-
ologic and technological issues must be considered in
program design and pass/fail criteria.
Screening Protocols in the Well-Infant Nursery
Many inpatient well-infant screening protocols provide
1 hearing screening and, when necessary, a repeat
screening no later than at the time of discharge from the
hospital, using the same technology both times. Use of
either technology in the well-infant nursery will detect
peripheral (conductive and sensory) hearing loss of 40
dB or greater.19 When automated ABR is used as the
single screening technology, neural auditory disorders
can also be detected.50 Some programs use a combina-
tion of screening technologies (OAE testing for the initial
screening followed by automated ABR for rescreening
[ie, 2-step protocol5]) to decrease the fail rate at dis-
charge and the subsequent need for outpatient follow-
up.34,35,37,51–53 With this approach, infants who do not pass
an OAE screening but subsequently pass an automated
ABR test are considered a screening “pass.” Infants in the
well-infant nursery who fail automated ABR testing
should not be rescreened by OAE testing and “passed,”
because such infants are presumed to be at risk of having
a subsequent diagnosis of auditory neuropathy/dyssyn-
chrony.
Screening Protocols in the NICU
An NICU is defined as a facility in which a neonatologist
provides primary care for the infant. Newborn units are
divided into 3 categories:
● Level I: basic care, well-infant nurseries
● Level II: specialty care by a neonatologist for infants at
moderate risk of serious complications
● Level III: a unit that provides both specialty and sub-
specialty care including the provision of life support
(mechanical ventilation)
A total of 120 level-II NICUs and 760 level-III NICUs
have been identified in the United States by survey, and
infants who have spent time in the NICU represent 10%
to 15% of the newborn population.54
The 2007 JCIH position statement includes neonates
at risk of having neural hearing loss (auditory neuropa-
thy/auditory dyssynchrony) in the target population to
be identified in the NICU,55–57 because there is evidence
that neural hearing loss results in adverse communica-
tion outcomes.22,50 Consequently, the JCIH recommends
ABR technology as the only appropriate screening tech-
nique for use in the NICU. For infants who do not pass
automated ABR testing in the NICU, referral should be
made directly to an audiologist for rescreening and,
when indicated, comprehensive evaluation, including
diagnostic ABR testing, rather than for general outpa-
tient rescreening.
Conveying Test Results
Screening results should be conveyed immediately to
families so that they understand the outcome and the
importance of follow-up when indicated. To facilitate
this process for families, primary health care profession-
als should work with EHDI team members to ensure
that:
● communications with parents are confidential and
presented in a caring and sensitive manner, preferably
face-to-face;
● educational materials are developed and disseminated
to families that provide accurate information at an
appropriate reading level and in a language they are
able to comprehend; and
● parents are informed in a culturally sensitive and un-
derstandable manner that their infant did not pass
screening and informed about the importance of
prompt follow-up; before discharge, an appointment
should be made for follow-up testing.
To facilitate this process for primary care physicians,
EHDI systems should ensure that medical professionals
receive:
● the results of the screening test (pass, did not pass, or
missed) as documented in the hospital medical chart;
and
● communication directly from a representative of the
hospital screening program regarding each infant in its
care who did not pass or was missed and recommen-
dations for follow-up.
Outpatient Rescreening for Infants Who Do Not Pass the
Birth Admission Screening
Many well-infant screening protocols will incorporate
an outpatient rescreening within 1 month of hospital
discharge to minimize the number of infants referred for
follow-up audiological and medical evaluation. The out-
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patient rescreening should include the testing of both
ears, even if only 1 ear failed the inpatient screening.
Outpatient screening at no later than 1 month of age
should also be available to infants who were discharged
before receiving the birth admission screening or who
were born outside a hospital or birthing center. State
EHDI coordinators should be aware of some of the fol-
lowing situations under which infants may be lost to the
UNHS system:
● Home births and other out-of-hospital births: states
should develop a mechanism to systematically offer
newborn hearing screening for all out-of-hospital
births.
● Across-state-border births: states should develop writ-
ten collaborative agreements among neighboring
states for sharing hearing-screening results and fol-
low-up information.
● Hospital-missed screenings: when infants are dis-
charged before the hearing screening is performed, a
mechanism should be in place for the hospital to con-
tact the family and arrange for an outpatient hearing
screening.
● Transfers to in-state or out-of-state hospitals: dis-
charge and transfer forms should contain the informa-
tion of whether a hearing screening was performed
and the results of any screening. The recipient hospital
should complete a hearing screening if one was not
previously performed or if there is a change in medical
status or a prolonged hospitalization.
● Readmissions: for readmissions in the first month of
life when there are conditions associated with poten-
tial hearing loss (eg, hyperbilirubinemia that requires
exchange transfusion or culture-positive sepsis), an
ABR screening should be performed before discharge.
Additional mechanisms for states to share hearing-
screening results and other medical information include
(l) incorporating the hearing-screening results in a state-
wide child health information system and (2) providing
combined metabolic screening and hearing-screening re-
sults to the primary care physician.
Conﬁrmation of Hearing Loss in Infants Referred From UNHS
Infants who meet the defined criteria for referral should
receive follow-up audiological and medical evaluations
with fitting of amplification devices, as appropriate, at no
later than 3 months of age. Once hearing loss is con-
firmed, coordination of services should be expedited by
the infant’s medical home and Part C coordinating agen-
cies for early intervention services, as authorized by the
Individuals With Disabilities Education Act, following
the EHDI algorithm developed by the AAP (Appendix 1).
Audiological Evaluation
Comprehensive audiological evaluation of newborn and
young infants who fail newborn hearing screening
should be performed by audiologists experienced in pe-
diatric hearing assessment. The initial audiological test
battery to confirm a hearing loss in infants must include
physiologic measures and, when developmentally ap-
propriate, behavioral methods. Confirmation of an in-
fant’s hearing status requires a test battery of audiologi-
cal test procedures to assess the integrity of the auditory
system in each ear, to estimate hearing sensitivity across
the speech frequency range, to determine the type of
hearing loss, to establish a baseline for further monitor-
ing, and to provide information needed to initiate am-
plification-device fitting. A comprehensive assessment
should be performed on both ears even if only 1 ear
failed the screening test.
Evaluation: Birth to 6 Months of Age
For infants from birth to a developmental age of approx-
imately 6 months, the test battery should include a child
and family history, an evaluation of risk factors for con-
genital hearing loss, and a parental report of the infant’s
responses to sound. The audiological assessment should
include:
● Child and family history.
● A frequency-specific assessment of the ABR using air-
conducted tone bursts and bone-conducted tone
bursts when indicated. When permanent hearing loss
is detected, frequency-specific ABR testing is needed
to determine the degree and configuration of hear-
ing loss in each ear for fitting of amplification de-
vices.
● Click-evoked ABR testing using both condensation
and rarefaction single-polarity stimulus, if there are
risk indicators for neural hearing loss (auditory neu-
ropathy/auditory dyssynchrony) such as hyperbiliru-
binemia or anoxia, to determine if a cochlear micro-
phonic is present.28 Furthermore, because some
infants with neural hearing loss have no risk indica-
tors, any infant who demonstrates “no response” on
ABR elicited by tone-burst stimuli must be evaluated
by a click-evoked ABR.55
● Distortion product or transient evoked OAEs.
● Tympanometry using a 1000-Hz probe tone.
● Clinician observation of the infant’s auditory behavior
as a cross-check in conjunction with electrophysi-
ologic measures. Behavioral observation alone is not
adequate for determining whether hearing loss is
present in this age group, and it is not adequate for the
fitting of amplification devices.
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Evaluation: 6 to 36 Months of Age
For subsequent testing of infants and toddlers at devel-
opmental ages of 6 to 36 months, the confirmatory
audiological test battery includes:
● Child and family history.
● Parental report of auditory and visual behaviors and
communication milestones.
● Behavioral audiometry (either visual reinforcement or
conditioned-play audiometry, depending on the
child’s developmental level), including pure-tone au-
diometry across the frequency range for each ear and
speech-detection and -recognition measures.
● OAE testing.
● Acoustic immittance measures (tympanometry and
acoustic reflex thresholds).
● ABR testing if responses to behavioral audiometry are
not reliable or if ABR testing has not been performed
in the past.
Other Audiological Test Procedures
At this time, there is insufficient evidence for use of the
auditory steady-state response as the sole measure of
auditory status in newborn and infant populations.58
Auditory steady-state response is a new evoked-poten-
tial test that can accurately measure auditory sensitivity
beyond the limits of other test methods. It can determine
frequency-specific thresholds from 250 Hz to 8 kHz.
Clinical research is being performed to investigate its
potential use in the standard pediatric diagnostic test
battery. Similarly, there are insufficient data for routine
use of acoustic middle-ear muscle reflexes in the initial
diagnostic assessment of infants younger than 4
months.59 Both tests could be used to supplement the
battery or could be included at older ages. Emerging
technologies, such as broad-band reflectance, may be
used to supplement conventional measures of middle-
ear status (tympanometry and acoustic reflexes) as the
technology becomes more widely available.59
Medical Evaluation
Every infant with confirmed hearing loss and/or middle-
ear dysfunction should be referred for otologic and other
medical evaluation. The purpose of these evaluations is
to determine the etiology of hearing loss, to identify
related physical conditions, and to provide recommen-
dations for medical/surgical treatment as well as referral
for other services. Essential components of the medical
evaluation include clinical history, family history of
childhood-onset permanent hearing loss, identification
of syndromes associated with early- or late-onset per-
manent hearing loss, a physical examination, and indi-
cated radiologic and laboratory studies (including ge-
netic testing). Portions of the medical evaluation, such as
urine culture for CMV, a leading cause of hearing loss,
might even begin in the birth hospital, particularly for
infants who spend time in the NICU.60–62
Pediatrician/Primary Care Physician
The infant’s pediatrician or other primary health care
professional is responsible for monitoring the general
health, development, and well-being of the infant. In
addition, the primary care physician must assume re-
sponsibility to ensure that the audiological assessment is
conducted on infants who do not pass screening and
must initiate referrals for medical specialty evaluations
necessary to determine the etiology of the hearing loss.
Middle-ear status should be monitored, because the
presence of middle-ear effusion can further compromise
hearing. The primary care physician must partner with
other specialists, including the otolaryngologist, to facil-
itate coordinated care for the infant and family. Because
30% to 40% of children with confirmed hearing loss will
demonstrate developmental delays or other disabilities,
the primary care physician should closely monitor de-
velopmental milestones and initiate referrals related to
suspected disabilities.63 The medical home algorithm for
management of infants with either suspected or proven
permanent hearing loss is provided in Appendix 1.15
The pediatrician or primary care physician should
review every infant’s medical and family history for the
presence of risk indicators that require monitoring for
delayed-onset or progressive hearing loss and should
ensure that an audiological evaluation is completed for
children at risk of hearing loss at least once by 24 to 30
months of age, regardless of their newborn screening
results.25 Infants with specific risk factors, such as those
who received ECMO therapy and those with CMV in-
fection, are at increased risk of delayed-onset or progres-
sive hearing loss64–67 and should be monitored closely. In
addition, the primary care physician is responsible for
ongoing surveillance of parent concerns about language
and hearing, auditory skills, and developmental mile-
stones of all infants and children regardless of risk status,
as outlined in the pediatric periodicity schedule pub-
lished by the AAP.16
Children with cochlear implants may be at increased
risk of acquiring bacterial meningitis compared with
children in the general US population.68 The CDC
recommends that all children with, and all potential
recipients of, cochlear implants follow specific recom-
mendations for pneumococcal immunization that ap-
ply to cochlear implant users and that they receive
age-appropriate Haemophilus influenzae type b vac-
cines. Recommendations for the timing and type of
pneumococcal vaccine vary with age and immuniza-
tion history and should be discussed with a health care
professional.69
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Otolaryngologist
Otolaryngologists are physicians and surgeons who di-
agnose, treat, and manage a wide range of diseases of the
head and neck and specialize in treating hearing and
vestibular disorders. They perform a full medical diag-
nostic evaluation of the head and neck, ears, and related
structures, including a comprehensive history and phys-
ical examination, leading to a medical diagnosis and
appropriate medical and surgical management. Often, a
hearing or balance disorder is an indicator of, or related
to, a medically treatable condition or an underlying sys-
temic disease. Otolaryngologists work closely with other
dedicated professionals, including physicians, audiolo-
gists, speech-language pathologists, educators, and oth-
ers, in caring for patients with hearing, balance, voice,
speech, developmental, and related disorders.
The otolaryngologist’s evaluation includes a compre-
hensive history to identify the presence of risk factors for
early-onset childhood permanent hearing loss, such as
family history of hearing loss, having been admitted to
the NICU for more than 5 days, and having received
ECMO (see Appendix 2).70,71
A complete head and neck examination for craniofa-
cial anomalies should document defects of the auricles,
patency of the external ear canals, and status of the
eardrum and middle-ear structures. Atypical findings on
eye examination, including irises of 2 different colors or
abnormal positioning of the eyes, may signal a syndrome
that includes hearing loss. Congenital permanent con-
ductive hearing loss may be associated with craniofacial
anomalies that are seen in disorders such as Crouzon
disease, Klippel-Feil syndrome, and Goldenhar syn-
drome.72 The assessment of infants with these congenital
anomalies should be coordinated with a clinical geneti-
cist.
In large population studies, at least 50% of congenital
hearing loss has been designated as hereditary, and
nearly 600 syndromes and 125 genes associated with
hearing loss have already been identified.72,73 The eval-
uation, therefore, should include a review of family
history of specific genetic disorders or syndromes, in-
cluding genetic testing for gene mutations such as GJB2
(connexin-26), and syndromes commonly associated
with early-onset childhood sensorineural hearing
loss72,74–76 (Appendix 2). As the widespread use of newly
developed conjugate vaccines decreases the prevalence
of infectious etiologies such as measles, mumps, rubella,
H influenzae type b, and childhood meningitis, the per-
centage of each successive cohort of early-onset hearing
loss attributable to genetic etiologies can be expected to
increase, prompting recommendations for early genetic
evaluations. Approximately 30% to 40% of children
with hearing loss have associated disabilities, which can
be of importance in patient management. The decision
to obtain genetic testing depends on informed family
choice in conjunction with standard confidentiality
guidelines.77
In the absence of a genetic or established medical
cause, a computed tomography scan of the temporal
bones may be performed to identify cochlear abnormal-
ities, such as Mondini deformity with an enlarged ves-
tibular aqueduct, which have been associated with pro-
gressive hearing loss. Temporal bone imaging studies
may also be used to assess potential candidacy for sur-
gical intervention, including reconstruction, bone-an-
chored hearing aid, and cochlear implantation. Recent
data have shown that some children with electrophysi-
ologic evidence suggesting auditory neuropathy/dyssyn-
chrony may have an absent or abnormal cochlear nerve
that may be detected with MRI.78
Historically, an extensive battery of laboratory and
radiographic studies was routinely recommended for
newborn infants and children with newly diagnosed
sensorineural hearing loss. However, emerging technol-
ogies for the diagnosis of genetic and infectious disorders
have simplified the search for a definitive diagnosis,
which obviates the need for costly diagnostic evaluations
in some instances.70,71,79
If, after an initial evaluation, the etiology remains
uncertain, an expanded multidisciplinary evaluation
protocol including electrocardiography, urinalysis, test-
ing for CMV, and further radiographic studies is indi-
cated. The etiology of neonatal hearing loss, however,
may remain uncertain in as many as 30% to 40% of
children. Once hearing loss is confirmed, medical clear-
ance for hearing aids and initiation of early intervention
should not be delayed while this diagnostic evaluation is
in process. Careful longitudinal monitoring to detect and
promptly treat coexisting middle-ear effusions is an es-
sential component of ongoing otologic management of
these children.
Other Medical Specialists
The medical geneticist is responsible for the interpreta-
tion of family history data, the clinical evaluation and
diagnosis of inherited disorders, the performance and
assessment of genetic tests, and the provision of genetic
counseling. Geneticists or genetic counselors are quali-
fied to interpret the significance and limitations of new
tests and to convey the current status of knowledge
during genetic counseling. All families of children with
confirmed hearing loss should be offered, and may ben-
efit from, a genetics evaluation and counseling. This
evaluation can provide families with information on
etiology of hearing loss, prognosis for progression, asso-
ciated disorders (eg, renal, vision, cardiac), and likeli-
hood of recurrence in future offspring. This information
may influence parents’ decision-making regarding inter-
vention options for their child.
Every infant with a confirmed hearing loss should
have an evaluation by an ophthalmologist to document
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visual acuity and rule out concomitant or late-onset
vision disorders such as Usher syndrome.1,80 Indicated
referrals to other medical subspecialists, including devel-
opmental pediatricians, neurologists, cardiologists, and
nephrologists, should be facilitated and coordinated by
the primary health care professional.
Early Intervention
Before newborn hearing screening was instituted uni-
versally, children with severe-to-profound hearing loss,
on average, completed the 12th grade with a 3rd- to
4th-grade reading level and language levels of a 9- to
10-year-old hearing child.81 In contrast, infants and chil-
dren with mild-to-profound hearing loss who are iden-
tified in the first 6 months of life and provided with
immediate and appropriate intervention have signifi-
cantly better outcomes than later-identified infants and
children in vocabulary development,82,83 receptive and
expressive language,12,84 syntax,85 speech produc-
tion,13,86–88 and social-emotional development.89 Children
enrolled in early intervention within the first year of life
have also been shown to have language development
within the normal range of development at 5 years of
age.31,90
Therefore, according to federal guidelines, once any
degree of hearing loss is diagnosed in a child, a referral
should be initiated to an early intervention program
within 2 days of confirmation of hearing loss (CFR
303.321d). The initiation of early intervention services
should begin as soon as possible after diagnosis of hear-
ing loss but at no later than 6 months of age. Even when
the hearing status is not determined to be the primary
disability, the family and child should have access to
intervention with a provider who is knowledgeable
about hearing loss.91
UNHS programs have been instituted throughout the
United States for the purpose of preventing the signifi-
cant and negative effects of hearing loss on the cognitive,
language, speech, auditory, social-emotional, and aca-
demic development of infants and children. To achieve
this goal, hearing loss must be identified as quickly as
possible after birth, and appropriate early intervention
must be available to all families and infants with perma-
nent hearing loss. Some programs have demonstrated
that most children with hearing loss and no additional
disabilities can achieve and maintain language develop-
ment within the typical range of children who have
normal hearing.12,13,85,90 Because these studies were de-
scriptive and not causal studies, the efficacy of specific
components of intervention cannot be separated from
the total provision of comprehensive services. Thus, the
family-centered philosophy, the intensity of services, the
experience and training of the provider, the method of
communication, the curricula, the counseling proce-
dures, the parent support and advocacy, and the deaf
and hard-of-hearing support and advocacy are all vari-
ables with unknown effects on the overall outcomes of
any individual child. The key component of providing
quality services is the expertise of the provider specific to
hearing loss. These services may be provided in the
home, a center, or a combination of the 2 locations.
The term “intervention services” is used to describe
any type of habilitative, rehabilitative, or educational
program provided to children with hearing loss. In some
cases of mild hearing losses, amplification technology
may be the only service provided. Some parents choose
only developmental assessment or occasional consulta-
tion, such as parents with infants who have unilateral
hearing losses. Children with high-frequency losses and
normal hearing in the low frequencies may only be seen
by a speech-language pathologist, and those with signif-
icant bilateral sensorineural hearing losses might be seen
by an educator of the deaf and receive additional ser-
vices.
Principles of Early Intervention
To ensure informed decision-making, parents of infants
with newly diagnosed hearing loss should be offered
opportunities to interact with other families who have
infants or children with hearing loss as well as adults and
children who are deaf or hard of hearing. In addition,
parents should also be offered access to professional,
educational, and consumer organizations and provided
with general information on child development, lan-
guage development, and hearing loss. A number of prin-
ciples and guidelines have been developed that offer a
framework for quality early intervention service delivery
systems for children who are deaf or hard of hearing and
their families.92 Foundational characteristics of develop-
ing and implementing early intervention programs in-
clude a family-centered approach, culturally responsive
practices, collaborative professional-family relationships
and strong family involvement, developmentally appro-
priate practice, interdisciplinary assessment, and com-
munity-based provision of services.
Designated Point of Entry
States should develop a single point of entry into inter-
vention specific for hearing impairment to ensure that,
regardless of geographic location, all families who have
infants or children with hearing loss receive information
about a full range of options regarding amplification and
technology, communication and intervention, and ac-
cessing appropriate counseling services. This state sys-
tem, if separate from the state’s Part C system, should
integrate and partner with the state’s Part C program.
Parental consent must be obtained according to state and
federal requirements to share the IFSP information with
providers and transmit data to the state EHDI coordina-
tor.
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Regular Developmental Assessment
To ensure accountability, individual, community, and
state health and educational programs should assume
the responsibility for coordinated, ongoing measure-
ment and improvement of EHDI process outcomes. Early
intervention programs must assess the language, cogni-
tive skills, auditory skills, speech, vocabulary, and social-
emotional development of all children with hearing loss
at 6-month intervals during the first 3 years of life by
using assessment tools that have been standardized on
children with normal hearing and norm-referenced as-
sessment tools that are appropriate to measure progress
in verbal and visual language.
The primary purpose of regular developmental mon-
itoring is to provide valuable information to parents
about the rate of their child’s development as well as
programmatic feedback concerning curriculum deci-
sions. Families also become knowledgeable about expec-
tations and milestones of typical development of hearing
children. Studies have shown that valid and reliable
documentation of developmental progress is possible
through parent questionnaires, analysis of videotaped
conversational interactions, and clinically administered
assessments.* Documentation of developmental progress
should be provided on a regular basis to parents and,
with parental release of information, to the medical
home and audiologist. Although criterion-referenced
checklists may provide valuable information for estab-
lishing intervention strategies and goals, these assess-
ment tools alone are not sufficient for parents and in-
tervention professionals to determine if a child’s
developmental progress is comparable with his or her
hearing peers.
Opportunities for Interaction With Other Parents of Children
With Hearing Loss
Intervention professionals should seek to involve par-
ents at every level of the EHDI process and develop true
and meaningful partnerships with parents. To reflect the
value of the contributions that selected parents make to
development and program components, these parents
should be paid as contributing staff members. Parent
representatives should be included in all advisory board
activities. In many states, parents have been integral and
often have taken leadership roles in the development of
policy, resource material, communication mechanisms,
mentoring and advocacy opportunities, dissemination of
information, and interaction with the deaf community
and other individuals who are deaf or hard of hearing.
Parents, often in partnership with people who are deaf
and hard of hearing, have also participated in the train-
ing of professionals. They should be participants in the
regular assessment of program services to ensure ongo-
ing improvement and quality assurance.
Opportunities for Interaction With Individuals Who Are Deaf
or Hard of Hearing
Intervention programs should include opportunities for
involvement of individuals who are deaf or hard of
hearing in all aspects of EHDI programs. Because inter-
vention programs serve children with mild-to-profound,
unilateral or bilateral, permanent conductive, and sen-
sory or neural hearing disorders, role models who are
deaf or hard of hearing can be significant assets to an
intervention program. These individuals can serve on
state EHDI advisory boards and be trained as mentors for
families and children with hearing loss who choose to
seek their support. Almost all families choose at some
time during their early childhood programs to seek out
both adults and child peers with hearing loss. Programs
should ensure that these opportunities are available and
can be delivered to families through a variety of com-
munications means, such as Web sites, e-mail, newslet-
ters, videos, retreats, picnics and other social events, and
educational forums for parents.
Provision of Communication Options
Research studies thus far of early-identified infants with
hearing loss have not found significant differences in the
developmental outcomes by method of communication
when measured at 3 years of age.† Therefore, a range of
options should be offered to families in a nonbiased
manner. In addition, there have been reports of children
with successful outcomes for each of the different meth-
ods of communication. The choice is a dynamic process
on a continuum, differs according to the individual
needs of each family, and can be adjusted as necessary
on the basis of a child’s rate of progress in developing
communication skills. Programs need to provide families
with access to skilled and experienced early intervention
professionals to facilitate communication and language
development in the communication option chosen by
the family.
Skills of the Early Intervention Professional
All studies with successful outcomes reported for early-
identified children who are deaf or hard of hearing have
intervention provided by specialists who are trained in
parent-infant intervention services.12,90,97 Early interven-
tion programs should develop mechanisms to ensure
that early intervention professionals have special skills
necessary for providing families with the highest quality
of service specific to children with hearing loss. Profes-
sionals with a background in deaf education, audiology,
and speech-language pathology will typically have the
skills needed for providing intervention services. Profes-
sionals should be highly qualified in their respective
fields and should be skilled communicators who are
knowledgeable and sensitive to the importance of en-
*Refs 10–13, 51, 85, 87–90, and 93–96. †Refs 10–13, 85, 87, 88, 90, 93, and 96.
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hancing families’ strengths and supporting their priori-
ties. When early intervention professionals have knowl-
edge of the principles of adult learning, it increases their
success with parents and other professionals.
Quality of Intervention Services
Children with confirmed hearing loss and their families
have the right to prompt access to quality intervention
services. For newborn infants with confirmed hearing
loss, enrollment into intervention services should begin
as soon after hearing-loss confirmation as possible and
no later than 6 months of age. Successful early interven-
tion programs (1) are family centered, (2) provide fam-
ilies with unbiased information on all options regarding
approaches to communication, (3) monitor develop-
ment at 6-month intervals with norm-referenced instru-
ments, (4) include individuals who are deaf or hard of
hearing, (5) provide services in a natural environment in
the home or in the center, (6) offer high-quality service
regardless of where the family lives, (7) obtain informed
consent, (8) are sensitive to cultural and language dif-
ferences and provide accommodations as needed, and
(9) conduct annual surveys of parent satisfaction.
Intervention for Special Populations of Infants and Young
Children
Developmental monitoring should also occur at regular
6-month intervals for special populations of children
with hearing loss, including those with minimal and
mild bilateral hearing loss,98 unilateral hearing loss,99,100
and neural hearing loss,22 because these children are at
risk of having speech and language delay. Research find-
ings indicate that approximately one third of children
with permanent unilateral loss experience significant
language and academic delays.99–101
Audiological Habilitation
Most infants and children with bilateral hearing loss and
many with unilateral hearing loss benefit from some
form of personal amplification device.32 If the family
chooses personal amplification for its infant, hearing-aid
selection and fitting should occur within 1 month of
initial confirmation of hearing loss even when additional
audiological assessment is ongoing. Audiological habili-
tation services should be provided by an audiologist who
is experienced with these procedures. Delay between
confirmation of the hearing loss and fitting of an ampli-
fication device should be minimized.51,102
Hearing-aid fitting proceeds optimally when the re-
sults of physiologic audiological assessment including
diagnostic ABR, OAE, and tympanometry and medical
examination are in accord. For infants who are below a
developmental age of 6 months, hearing-aid selection
will be based on physiologic measures alone. Behavioral
threshold assessment with visual reinforcement audiom-
etry should be obtained as soon as possible to cross-
check and augment physiologic findings (see www.au-
diology.org).
The goal of amplification-device fitting is to provide
the infant with maximum access to all of the acoustic
features of speech within an intensity range that is safe
and comfortable. That is, amplified speech should be
comfortably above the infant’s sensory threshold but
below the level of discomfort across the speech fre-
quency range for both ears. To accomplish this in in-
fants, amplification-device selection, fitting, and verifi-
cation should be based on a prescriptive procedure that
incorporates individual real-ear measures that account
for each infant’s ear-canal acoustics and hearing loss.32
Validation of the benefits of amplification, particularly
for speech perception, should be examined in the clinical
setting as well as in the child’s typical listening environ-
ments. Complementary or alternative technology, such
as frequency modulation (FM) systems or cochlear im-
plants, may be recommended as the primary and/or
secondary listening device depending on the degree of
the infant’s hearing loss, the goals of auditory habilita-
tion, the infant’s acoustic environments, and the fami-
ly’s informed choices.3 Monitoring of amplification, as
well as the long-term validation of the appropriateness
of the individual habilitation program, requires ongoing
audiological assessment along with electroacoustic, real-
ear, and functional checks of the hearing instruments.
As the hearing loss becomes more specifically defined
through audiological assessments and as the child’s ear-
canal acoustics change with growth, refinement of the
individual prescriptive hearing-aid gain and output tar-
gets is necessary. Monitoring also includes periodic val-
idation of communication, social-emotional, and cogni-
tive development and, later, academic performance to
ensure that progress is commensurate with the child’s
abilities. It is possible that infants and young children
with measurable residual “hearing” (auditory responses)
and well-fit amplification devices may fail to develop
auditory skills necessary for successful spoken commu-
nication. Ongoing validation of the amplification device
is accomplished through interdisciplinary evaluation and
collaboration with the early intervention team and fam-
ily.
Cochlear implantation should be given careful con-
sideration for any child who seems to receive limited
benefit from a trial with appropriately fitted hearing
aids. According to US Food and Drug Administration
guidelines, infants with profound bilateral hearing loss
are candidates for cochlear implantation at 12 months of
age and children with bilateral severe hearing loss are
eligible at 24 months of age. The presence of develop-
mental conditions (eg, developmental delay, autism) in
addition to hearing loss should not, as a rule, preclude
the consideration of cochlear implantation for an infant
or child who is deaf. Benefits from hearing aids and
cochlear implants in children with neural hearing loss
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have also been documented. The benefit of acoustic
amplification for children with neural hearing loss is
variable.28,103 Thus, a trial fitting is indicated for infants
with neural hearing loss until the usefulness of the fit-
ting can be determined. Neural hearing loss is a hetero-
geneous condition; the decision to continue or discon-
tinue use of hearing aids should be made on the basis
of the benefit derived from amplification. Use of co-
chlear implants in neural hearing loss is growing, and
positive outcomes have been reported for many chil-
dren.28
Infants and young children with unilateral hearing
loss should also be assessed for appropriateness of hear-
ing-aid fitting. Depending on the degree of residual
hearing in unilateral loss, a hearing aid may or may not
be indicated. Use of “contralateral routing of signals”
amplification for unilateral hearing loss in children is not
recommended.104 Research is currently underway to de-
termine how to best manage unilateral hearing loss in
infants and young children.
The effect of otitis media with effusion (OME) is
greater for infants with sensorineural hearing loss than
for those with normal cochlear function.73 Sensory or
permanent conductive hearing loss is compounded by
additional transient conductive hearing loss associated
with OME. OME further reduces access to auditory cues
necessary for the development of spoken English. OME
also negatively affects the prescriptive targets of the
hearing-aid fitting, decreasing auditory awareness and
requiring adjustment of the amplification characteristics.
Prompt referral to either the primary care physician or
an otolaryngologist for treatment of persistent OME is
indicated in infants with sensorineural hearing loss.105
Definitive resolution of OME should never delay the
fitting of an amplification device.73,106
Medical and Surgical Intervention
Medical intervention is the process by which a physician
provides medical diagnosis and direction for medical
and/or surgical treatment options for hearing loss and/or
related medical disorder(s) associated with hearing loss.
Treatment varies from the removal of cerumen and the
treatment of OME to long-term plans for reconstructive
surgery and assessment of candidacy for cochlear im-
plants. If necessary, surgical treatment of malformation
of the outer and middle ears, including bone-anchored
hearing aids, should be considered in the intervention
plan for infants with permanent conductive or mixed
hearing loss when they reach an appropriate age.
Communication Assessment and Intervention
Language is acquired with greater ease during certain sen-
sitive periods of infant and toddler development.107–109
The process of language acquisition includes learning the
precursors of language, such as the rules that pertain to
selective attention and turn taking.20,110,111 Cognitive, so-
cial, and emotional development are influenced by the
acquisition of language. Development in these areas is
synergistic. A complete language evaluation should be
performed at regular intervals for infants and toddlers
with hearing loss. The evaluation should include an
assessment of oral, manual, and/or visual mechanisms as
well as cognitive abilities.
A primary focus of language intervention is to support
families in fostering the communication abilities of their
infants and toddlers who are deaf or hard of hearing.20
Spoken- and/or sign-language development should be
commensurate with the child’s age and cognitive abili-
ties and should include acquisition of phonologic (for
spoken language), visual/spatial/motor (for signed lan-
guage), morphologic, semantic, syntactic, and pragmatic
skills, depending on the family’s preferred mode of com-
munication.
Early intervention professionals should follow family-
centered principles to assist in developing communica-
tive competence of infants and toddlers who are deaf or
hard of hearing.112–114 Families should be provided with
information specific to language development and access
to peer and language models as well as family-involved
activities that facilitate language development of chil-
dren with normal hearing and children who are hard of
hearing or deaf.115,116 Depending on family choices, fam-
ilies should be offered access to children and adults with
hearing loss who are appropriate and competent lan-
guage models. Information on spoken language and
signed language, such as American Sign Language117 and
cued speech, should be provided.
Continued Surveillance, Screening, and Referral of Infants and
Toddlers
Appendix 2 presents 11 risk indicators that are associ-
ated with either congenital or delayed-onset hearing
loss. A single list of risk indicators is presented in the
current JCIH statement, because there is significant
overlap among those indicators associated with congen-
ital/neonatal hearing loss and those associated with de-
layed-onset/acquired or progressive hearing loss.
Heightened surveillance of all infants with risk indica-
tors, therefore, is recommended. There is a significant
change in the definition of risk-indicator 3, which has
been modified from NICU stay more than 48 hours to
NICU stay more than 5 days. Consistent with 2000 JCIH
position statement,3 the 2007 position statement recom-
mends use of risk indicators for hearing loss for 3 pur-
poses. Historically, the first use of risk indicators is for
the identification of infants who should receive audio-
logical evaluation but who live in geographic locations
(eg, developing nations, remote areas) where universal
hearing screening is not yet available.‡ This use has
become less common as a result of the expansion of
‡Refs 3, 19, 21, 24, 25, 64, and 118–124.
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UNHS. The second purpose of risk-indicator identifica-
tion is to help identify infants who pass the neonatal
screening but are at risk of developing delayed-onset
hearing loss and, therefore, should receive ongoing med-
ical, speech and language, and audiological surveillance.
Third, the risk indicators are used to identify infants who
may have passed neonatal screening but have mild
forms of permanent hearing loss.25
Because some important indicators, such as family
history of hearing loss, may not be determined during
the course of UNHS,14,72 the presence of all risk indicators
for acquired hearing loss should be determined in the
medical home during early well-infant visits. Risk indi-
cators that are marked with a section symbol in Appen-
dix 2 are of greater concern for delayed-onset hearing
loss. Early and more frequent assessment may be indi-
cated for children with CMV infection,118,125,126 syn-
dromes associated with progressive hearing loss,72
neurodegenerative disorders,72 trauma,127–129 or culture-
positive postnatal infections associated with sensorineu-
ral hearing loss130,131; for children who have received
ECMO64 or chemotherapy132; and when there is care-
giver concern or a family history of hearing loss.16
For all infants with and without risk indicators for
hearing loss, developmental milestones, hearing skills,
and parent concerns about hearing, speech, and lan-
guage skills should be monitored during routine medical
care consistent with the AAP periodicity schedule.
The JCIH has determined that the previously recom-
mended approach to follow-up of infants with risk indi-
cators for hearing loss only addressed children with
identifiable risk indicators and failed to consider the
possibility of delayed-onset hearing loss in children
without identifiable risk indicators. In addition, concerns
were raised about feasibility and cost associated with the
2000 JCIH recommendation for audiological monitoring
of all infants with risk indicators at 6-month intervals.
Because approximately 400 000 infants are cared for
annually in NICUs in the United States, and the 2000
JCIH recommendation included audiology assessments
at 6-month intervals from 6 months to 36 months of age
for all infants admitted to an NICU for more than 48
hours, an unreasonable burden was placed on both pro-
viders of audiology services and families. In addition,
there was no provision for identification of delayed-
onset hearing loss in infants without an identifiable risk
indicator. Data from 2005 for 12 388 infants discharged
from NICUs in the National Perinatal Information Net-
work indicated that 52% of infants were discharged
within the first 5 days of life, and these infants were
significantly less likely to have an identified risk indica-
tor for hearing loss other than NICU stay. Therefore, the
2007 JCIH recommends an alternative, more inclusive
strategy of surveillance of all children within the medical
home based on the pediatric periodicity schedule. This
protocol will permit the detection of children with either
missed neonatal or delayed-onset hearing loss irrespec-
tive of the presence or absence of a high-risk indicator.
The JCIH recognizes that an optimal surveillance and
screening program within the medical home would in-
clude the following:
● At each visit, consistent with the AAP periodicity
schedule, infants should be monitored for auditory
skills, middle-ear status, and developmental mile-
stones (surveillance). Concerns elicited during surveil-
lance should be followed by administration of a vali-
dated global screening tool.133 A validated global
screening tool is administered to all infants at 9, 18,
and 24 to 30 months or, if there is physician or pa-
rental concern about hearing or language, sooner.133
● If an infant does not pass the speech-language portion
of the global screening in the medical home or if there
is physician or caregiver concern about hearing or
spoken-language development, the child should be
referred immediately for further evaluation by an au-
diologist and a speech-language pathologist for a
speech and language evaluation with validated
tools.133
● Once hearing loss is diagnosed in an infant, siblings
who are at increased risk of having hearing loss should
be referred for audiological evaluation.14,75,134,135
● All infants with a risk indicator for hearing loss (Ap-
pendix 2), regardless of surveillance findings, should
be referred for an audiological assessment at least once
by 24 to 30 months of age. Children with risk indica-
tors that are highly associated with delayed-onset
hearing loss, such as having received ECMO or having
CMV infection, should have more frequent audiologi-
cal assessments.
● All infants for whom the family has significant con-
cerns regarding hearing or communication should be
promptly referred for an audiological and speech-lan-
guage assessment.
● A careful assessment of middle-ear status (using pneu-
matic otoscopy and/or tympanometry) should be
completed at all well-child visits, and children with
persistent middle-ear effusion that last for 3 months or
longer should be referred for otologic evaluation.136
Protecting the Rights of Infants and Families
Each agency or institution involved in the EHDI process
shares responsibility for protecting infant and family
rights in all aspects of UNHS, including access to infor-
mation including potential benefits and risks in the fam-
ily’s native language, input into decision-making, and
confidentiality.77 Families should receive information
about childhood hearing loss in easily understood lan-
guage. Families have the right to accept or decline hear-
ing screening or any follow-up care for their newborn
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infant within the statutory regulations, just as they have
for any other screening or evaluation procedures or
intervention.
EHDI data merit the same level of confidentiality and
security afforded all other health care and education
information in practice and law. The infant’s family has
the right to confidentiality of the screening and fol-
low-up assessments and the acceptance or rejection of
suggested intervention(s). In compliance with federal
and state laws, mechanisms should be established that
ensure parental release and approval of all communica-
tions regarding the infant’s test results, including those
to the infant’s medical home and early intervention–
coordinating agency and programs. The Health Insur-
ance Portability and Accountability Act (Pub L No. 104-
191 [1996]) regulations permit the sharing of health
information among health care professionals.
Information Infrastructure
In its 2000 position statement,3 the JCIH recommended
development of uniform state registries and national
information databases that incorporate standardized
methodology, reporting, and system evaluation. EHDI
information systems are to provide for the ongoing and
systematic collection, analysis, and interpretation of data
in the process of measuring and reporting associated
program services (eg, screening, evaluation, diagnosis,
and/or intervention). These systems are used to guide
activities, planning, implementation, and evaluation of
programs and to formulate research hypotheses.
EHDI information systems are generally authorized
by legislators and implemented by public health officials.
These systems vary from a simple system that collects
data from a single source to electronic systems that re-
ceive data from many sources in multiple formats. The
number and variety of systems will likely increase with
advances in electronic data interchange and integration
of data, which will also heighten the importance of
patient privacy, data confidentiality, and system secu-
rity. The appropriate agencies and/or officials should be
consulted for any projects regarding public health sur-
veillance.69
Federal and state agencies are collaborating in the
standardization of data definitions to ensure the value of
data sets and to prevent misleading or unreliable infor-
mation. Information management is used to improve
services to infants and their families; to assess the quan-
tity and timeliness of screening, evaluation, and enroll-
ment into intervention; and to facilitate collection of
demographic data on neonatal and infant hearing loss.
The JCIH endorses the concept of a limited national
database to permit documentation of the demographics
of neonatal hearing loss, including prevalence and etiol-
ogy across the United States. The information obtained
from the information-management system should assist
both the primary health care professional and the state
health agency in measuring quality indicators associated
with program services (eg, screening, diagnosis, and in-
tervention). The information system should provide
measurement tools to determine the degree to which
each process is stable and sustainable and conforms to
program benchmarks. Timely and accurate monitoring
of relevant quality measures is essential.
Since 1999, the CDC and the Directors of Speech and
Hearing Programs in State Health and Welfare Agencies
(DSHPSHWA) have collected annual aggregate EHDI
program data needed to address the national EHDI goals.
In 1999, a total of 22 states provided data for the DSHP-
SHWA survey. Participation had increased to 48 states, 1
territory, and the District of Columbia in 2003. However,
many programs have been unable to respond to all the
questions on the survey because of lack of a statewide
comprehensive data-management and reporting system.
The Government Performance and Results Act
(GPRA) of 1993 (Pub L No. 103-62) requires that federal
programs establish measurable goals approved by the US
Office of Management and Budget (OMB) that can be
reported as part of the budgetary process, thus linking
future funding decisions with performance. The HRSA
has modified its reporting requirements for all grant
programs. The GPRA measures that must be reported to
the OMB by the MCHB annually for the EHDI program
are:
● the number of infants screened for hearing loss before
discharge from the hospital;
● the number of infants with confirmed hearing loss at
no later than 3 months of age;
● the number of infants enrolled in a program of early
intervention at no later than 6 months of age;
● the number of infants with confirmed or suspected
hearing loss referred to an ongoing source of compre-
hensive health care (ie, medical home); and
● the number of children with nonsyndromic hearing
loss who have developmentally appropriate language
and communication skills at school entry.
One GPRA measure that must be reported to the
OMB by the CDC annually for the EHDI program is the
percentage of newborn infants with a positive screening
result for hearing loss who are subsequently lost to
follow-up.
EHDI programs have made tremendous gains in their
ability to collect, analyze, and interpret data in the pro-
cess of measuring and reporting associated program ser-
vices. However, only a limited number of EHDI pro-
grams are currently able to accurately report the number
of infants screened, evaluated, and enrolled in interven-
tion, the age of time-related objectives (eg, screening by
1 month of age), and the severity or laterality of hearing
loss. This is complicated by the lack of data standards and
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by privacy issues within the regulations of the Family
Educational Rights and Privacy Act of 1974 (Pub L No.
93-380).
Given the current lack of standardized and readily
accessible sources of data, the CDC EHDI program, in
collaboration with the DSHPSHWA, developed a revised
survey to obtain annual EHDI data from states and ter-
ritories in a consistent manner to assess progress toward
meeting the national EHDI goals and the Healthy People
2010 objectives. In October 2006, the OMB, which is
responsible for reviewing all government surveys, ap-
proved the new EHDI hearing screening and follow-up
survey. To facilitate this effort, the CDC EHDI Data Com-
mittee is establishing the minimum data elements and
definitions needed for information systems to be used to
assess progress toward the national EHDI goals.
The JCIH encourages the CDC and HRSA to continue
their efforts to identify barriers and explore possible
solutions with EHDI programs to ensure that children in
each state who seek hearing-related services in states
other than where they reside receive all recommended
screening and follow-up services. EHDI systems should
also be designed to promote the sharing of data regard-
ing early hearing loss through integration and/or linkage
with other child health information systems. The CDC
currently provides funds to integrate the EHDI system
with other state/territorial screening, tracking, and sur-
veillance programs that identify children with special
health care needs. Grantees of the MCHB are encour-
aged to link hearing-screening data with such child
health data sets as electronic birth certificates, vital sta-
tistics, birth defects registries, metabolic or newborn
dried “blood-spot” screenings, immunization registries,
and others.
To promote the best use of public health resources,
EHDI information systems should be evaluated periodi-
cally, and such evaluations should include recommen-
dations for improving quality, efficiency, and usefulness.
The appropriate evaluation of public health surveillance
systems becomes paramount as these systems adapt to
revise case definitions, address new health-related
events, adopt new information technology, ensure data
confidentiality, and assess system security.69
Currently, federal sources of systems support include
Title V block grants to states for maternal and child
health care services, Title XIX (Medicaid) federal and
state funds for eligible children, and competitive US
Department of Education personnel preparation and re-
search grants. The NIDCD provides grants for research
related to early identification and intervention for chil-
dren who are deaf or hard of hearing.137
Universities should assume responsibility for special-
track, interdisciplinary, professional education programs
for early intervention for infants and children with hear-
ing loss. Universities should also provide training in fam-
ily systems, the grieving process, cultural diversity, au-
ditory skill development, and deaf culture. There is a
critical need for in-service and preservice training of
professionals related to EHDI programs, which is partic-
ularly acute for audiologists and early interventionists
with expertise in hearing loss. This training will require
increased and sustained funding for personnel prepara-
tion.
Benchmarks and Quality Indicators
The JCIH supports the concept of regular measurements
of performance and recommends routine monitoring of
these measures for interprogram comparison and con-
tinuous quality improvement. Performance benchmarks
represent a consensus of expert opinion in the field of
newborn hearing screening and intervention. The
benchmarks are the minimal requirements that should
be attained by high-quality EHDI programs. Frequent
measures of quality permit prompt recognition and cor-
rection of any unstable component of the EHDI pro-
cess.138
Quality Indicators for Screening
● Percentage of all newborn infants who complete
screening by 1 month of age; the recommended
benchmark is more than 95% (age correction for pre-
term infants is acceptable).
● Percentage of all newborn infants who fail initial
screening and fail any subsequent rescreening before
comprehensive audiological evaluation; the recom-
mended benchmark is less than 4%.
Quality Indicators for Confirmation of Hearing Loss
● Of infants who fail initial screening and any subse-
quent rescreening, the percentage who complete a
comprehensive audiological evaluation by 3 months
of age; the recommended benchmark is 90%.
● For families who elect amplification, the percentage of
infants with confirmed bilateral hearing loss who re-
ceive amplification devices within 1 month of confir-
mation of hearing loss; the recommended benchmark
is 95%.
Quality Indicators for Early Intervention
● For infants with confirmed hearing loss who qualify
for Part C services, the percentage for whom parents
have signed an IFSP by no later than 6 months of age;
the recommended benchmark is 90%.
● For children with acquired or late-identified hearing
loss, the percentage for whom parents have signed an
IFSP within 45 days of the diagnosis; the recom-
mended benchmark is 95%.
● The percentage of infants with confirmed hearing loss
who receive the first developmental assessment with
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standardized assessment protocols (not criterion refer-
ence checklists) for language, speech, and nonverbal
cognitive development by no later than 12 months of
age; the recommended benchmark is 90%.
CURRENT CHALLENGES, OPPORTUNITIES, AND FUTURE
DIRECTIONS
Despite the tremendous progress made since 2000, there
are challenges to the success of the EHDI system.
Challenges
All of the following listed challenges are considered im-
portant for the future development of successful EHDI
systems:
● Too many children are lost between the failed screen-
ing and the rescreening and between the failed re-
screening and the diagnostic evaluation.
● There is a shortage of professionals with skills and
expertise in both pediatrics and hearing loss, including
audiologists, deaf educators, speech-language pathol-
ogists, early intervention professionals, and physi-
cians.
● There is often a lack of timely referral for diagnosis of,
and intervention for, suspected hearing loss in chil-
dren.
● Consistent and stable state and federal funding is
needed for program sustainability.
● When compared with services provided for adults,
pediatric services in all specialties are poorly reim-
bursed.
● Access to uniform Part C services is inadequate among
states and within states.
● There is a lack of integrated state data-management
and -tracking systems.
● Demographics and cultural diversity are changing rap-
idly.
● Funding for hearing aids, loaner programs, cochlear
implants, and FM systems is needed.
● There is a lack of specialized services for children with
multiple disabilities and hearing loss.
● Children may not qualify for services (state Part C
guidelines) before demonstrating language delays
(prevention model versus deficit model).
● Children may not qualify for assistive technology (pre-
vention model versus deficit model).
● There is a lack of in-service education for key profes-
sionals.
● There are regulatory barriers to sharing information
among providers and among states.
● No national standards exist for the calibration of OAE
or ABR instrumentation, and there is a lack of uniform
performance standards.
Opportunities for System Development and Research
● Establish programs to ensure the development of com-
munication for infants and children with all degrees
and types of hearing loss, allowing them access to all
educational, social, and vocational opportunities
throughout their life span.
● Develop improved, rapid, reliable screening technol-
ogy designed to differentiate specific types of hearing
loss.
● Develop and validate screening technologies for iden-
tifying minimal hearing loss.
● Develop state data-management systems with the ca-
pacity for the accurate determination of the preva-
lence for delayed-onset or progressive hearing loss.
● Develop state data-tracking systems to follow infants
with suspected and confirmed hearing loss through
individual state EHDI programs.
● Track the certification credentials of the service pro-
viders for children with confirmed hearing loss who
are receiving Part C early intervention services and
early childhood special education.
● Track genetic, environmental, and pharmacologic fac-
tors that contribute to hearing loss, thus allowing for
tailored prevention and intervention strategies.
● Continue to refine electrophysiologic diagnostic tech-
niques, algorithms, and equipment to enable frequen-
cy-specific threshold assessment for use with very
young infants.
● Continue to refine techniques to improve the selec-
tion and fitting of appropriate amplification devices in
infants and young children.
● Conduct translational research pertaining to young
children with hearing loss, in particular, genetic, diag-
nostic, and outcomes studies.
● Initiate prospective population-based studies to deter-
mine the prevalence and natural history of auditory
neural conduction disorders.
● Conduct efficacy studies to determine appropriate
early intervention strategies for infants and children
with all degrees and types of hearing loss.
● Conduct additional studies on the efficacy of interven-
tion for infants and children who receive cochlear
implants at younger than 2 years.
● Conduct additional studies on the efficacy of hearing-
aid use in infants and children younger than 2 years.
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● Conduct additional studies of the auditory develop-
ment of children who have appropriate amplification
devices in early life.
● Expand programs within health, social service, and
education agencies associated with early intervention
and Head Start programs to accommodate the needs of
the increasing numbers of early-identified children.
● Adapt education systems to capitalize on the abilities
of children with hearing loss who have benefited from
early identification and intervention.
● Develop genetic and medical procedures that will de-
termine more rapidly the etiology of hearing loss.
● Ensure transition from Part C (early intervention) to
Part B (education) services in ways that encourage
family participation and ensure minimal disruption of
child and family services.
● Study the effects of parents’ participation in all aspects
of early intervention.
● Test the utility of a limited national data set and de-
velop nationally accepted indicators of EHDI system
performance.
● Encourage the identification and development of cen-
ters of expertise in which specialized care is provided
in collaboration with local service providers.
● Obtain the perspectives of individuals who are deaf or
hard of hearing in developing policies regarding med-
ical and genetic testing and counseling for families
who carry genes associated with hearing loss.139
CONCLUSIONS
Since the 2000 JCIH statement, tremendous and rapid
progress has been made in the development of EHDI
systems as a major public health initiative. The percent-
age of infants screened annually in the United States has
increased from 38% to 95%. The collaboration at all
levels of professional organizations, federal and state
government, hospitals, medical homes, and families has
contributed to this remarkable success. New research
initiatives to develop more sophisticated screening and
diagnostic technology, improved digital hearing-aid and
FM technologies, speech-processing strategies in co-
chlear implants, and early intervention strategies con-
tinue. Major technological breakthroughs have been
made in facilitating the definitive diagnosis of both ge-
netic and nongenetic etiologies of hearing loss. In addi-
tion, outcomes studies to assess the long-term outcomes
of special populations, including infants and children
with mild and unilateral hearing loss, neural hearing
loss, and severe or profound hearing loss managed with
cochlear implants, have been providing information on
the individual and societal impact and the factors that
contribute to an optimized outcome. It is apparent, how-
ever, that there are still serious challenges to be over-
come and system barriers to be conquered to achieve
optimal EHDI systems in all states in the next 5 years.
Follow-up rates remain poor in many states, and fund-
ing for amplification in children is inadequate. Funding
to support outcome studies is necessary to guide inter-
vention and to determine factors other than hearing loss
that affect child development. The ultimate goal, to op-
timize communication, social, academic, and vocational
outcomes for each child with permanent hearing loss,
must remain paramount.
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APPENDIX 2: RISK INDICATORS ASSOCIATEDWITH
PERMANENT CONGENITAL, DELAYED-ONSET, OR
PROGRESSIVE HEARING LOSS IN CHILDHOOD
Risk indicators that are marked with a “§” are of greater
concern for delayed-onset hearing loss.
1. Caregiver concern§ regarding hearing, speech, lan-
guage, or developmental delay.62
2. Family history§ of permanent childhood hearing
loss.24,140
3. Neonatal intensive care of more than 5 days or any of
the following regardless of length of stay: ECMO,§
assisted ventilation, exposure to ototoxic medications
(gentimycin and tobramycin) or loop diuretics (furo-
semide/Lasix), and hyperbilirubinemia that requires
exchange transfusion.64,131
4. In utero infections, such as CMV,§ herpes, rubella,
syphilis, and toxoplasmosis.64–67,125,126
5. Craniofacial anomalies, including those that involve
the pinna, ear canal, ear tags, ear pits, and temporal
bone anomalies.24
6. Physical findings, such as white forelock, that are as-
sociated with a syndrome known to include a senso-
rineural or permanent conductive hearing loss.24
7. Syndromes associated with hearing loss or progres-
sive or late-onset hearing loss,§ such as neurofibro-
matosis, osteopetrosis, and Usher syndrome131; other
frequently identified syndromes include Waarden-
burg, Alport, Pendred, and Jervell and Lange-
Nielson.72
8. Neurodegenerative disorders,§ such as Hunter syn-
drome, or sensory motor neuropathies, such as Fried-
reich ataxia and Charcot-Marie-Tooth syndrome.131
9. Culture-positive postnatal infections associated with
sensorineural hearing loss,§ including confirmed
bacterial and viral (especially herpes viruses and
varicella) meningitis.130,131,141
10. Head trauma, especially basal skull/temporal bone
fracture§ that requires hospitalization.127–129
11. Chemotherapy.§132
APPENDIX 1 Algorithm for Hearing Screening. Available at: http://www.medicalhomeinfo.org/screening/Screen%20Materials/Algorithm.pdf
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